| Literature DB >> 27270415 |
Elizabeth E Palmer1,2, Kelsey E Jarrett3,4, Rani K Sachdev1,5, Fatema Al Zahrani6, Mais Omar Hashem6, Niema Ibrahim6, Hugo Sampaio1,5, Tejaswi Kandula1,5, Rebecca Macintosh5, Rajat Gupta3, Donna M Conlon7, Jeffrey T Billheimer7, Daniel J Rader7, Kouichi Funato8, Christopher J Walkey9, Chang Seok Lee3, Christine Loo1,10, Susan Brammah11, George Elakis10, Ying Zhu2,10, Michael Buckley10, Edwin P Kirk1,5,10, Ann Bye1,5, Fowzan S Alkuraya6, Tony Roscioli5,12,13, William R Lagor14.
Abstract
We report an individual who presented with severe neurodevelopmental delay and an intractable infantile-onset seizure disorder. Exome sequencing identified a homozygous single nucleotide change that abolishes a splice donor site in the ARV1 gene (c.294 + 1G > A homozygous). This variant completely prevented splicing in minigene assays, and resulted in exon skipping and an in-frame deletion of 40 amino acids in primary human fibroblasts (NP_073623.1: p.(Lys59_Asn98del). The p.(Lys59_Asn98del) and previously reported p.(Gly189Arg) ARV1 variants were evaluated for protein expression and function. The p.(Gly189Arg) variant partially rescued the temperature-dependent growth defect in arv1Δ yeast, while p.(Lys59-Asn98del) completely failed to rescue at restrictive temperature. In contrast to wild type human ARV1, neither variant expressed detectable levels of protein in mammalian cells. Mice with a neuronal deletion of Arv1 recapitulated the human phenotype, exhibiting seizures and a severe survival defect in adulthood. Our data support ARV1 deficiency as a cause of autosomal recessive epileptic encephalopathy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27270415 PMCID: PMC5181598 DOI: 10.1093/hmg/ddw157
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150